Galderma Group AG , the pure-play dermatology category leader, has announced the launch of its Initial Public Offering on the SIX Swiss Exchange. According to various market sources and reports, the Skincare business is looking to
Niederer Kraft Frey has advised Mandi Ventures on its investment in Cultivated Biosciences SA. Mandi is an early-stage venture capital fund, focused on accelerating the adoption of disruptive technologies in the food and agriculture industries.
The American supplier of analytical instruments, Thermo Fisher Scientific, with annual revenues of close to US$50 billion, has successfully completed the issuance of its inaugural Swiss franc bonds. It is reportedly the largest foreign Swiss
Baker McKenzie Switzerland has advised Commerzbank Aktiengesellschaft, Zurich branch, on guarantee facility agreements for Calik Enerji Swiss AG, totaling USD 586.25 million. This included a guarantee agreement covered by Swiss Export Risk Insurance (SERV). Guaranteed by
Abrantix and B2 Payment Solutions have combined their expertise and knowledge to found the joint venture company PaytestLab AG. This represents a strategic move to revolutionise the field of automated payment software testing by combining
Swiss Prime Site has successfully placed green bonds in the aggregate principal amount of of CHF 250 million 1.80% due 2030. The bonds were issued by Swiss Prime Site Finance AG
A privately owned residential real estate in Canton Zürich, comprising of severalapartments in Zurich City, has been sold to several private investors. Bär & Karrer acted as legal advisor of Rahn+Bodmer Co.
UBS Switzerland AG has successfully completed its issuance of Covered Bonds under its covered bond program of €1billion 3.304% Covered Bonds due on March 2029. The Covered Bonds are governed by Swiss law and have been provisionally
L Catterton, a leading US private equity firm, entered into a definitive agreement to acquire a significant stake in AmaWaterways, a global, award-winning luxury river cruise line, from a consortium of investors led by Certares.
Novartis AG, the Swiss multinational pharmaceutical corporation based in Basel, has appointed Alejandro Bes (pictured) as its global head of legal for the Immunology business unit. The lawyer steps into the role as his predecessor,
